InsidersTradesSigma
Track the Fortress Biotech, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Fortress Biotech, Inc. has logged 80 insider filings. Market capitalisation: €111m. The latest transaction was filed on 24 June 2026 (Attribution). Among the most active insiders: ROSENWALD LINDSAY A MD. All data is accessible without an account.
80
Insider Decl.
n/a
Thresholds
€8m
22 ops.
Buy Volume
€92,941
2 ops.
Sell Volume
42Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,469 of 29,063 companies
40.6
score / 100
Value14
Quality68
FCF yld-71%
Earn yld-2.0%
EV/EBITDA·
ROE116%
Gross mgn67%
Net mgn-3.0%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 June 2026
Declarations80 total
475,424 shares0common stock, par value $0.001SEC:0001038977-26-000002:0
475,424 shares0Common stock, par value $0.001SEC:0000941841-26-000002:0
27,322 shares0common stock, par value $0.001SEC:0001772558-26-000002:0
27,322 shares0common stock, par value $0.001SEC:0001529687-26-000002:0
27,322 shares0Common Stock, par value $0.001SEC:0001294517-26-000002:0
27,322 shares0common stock, par value $0.001SEC:0001172659-26-000002:0
49,383 shares0Common Stock, par value $0.001SEC:0001415889-25-000425:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000444:0
454,153 shares0common stock, par value $0.001SEC:0001415889-25-000402:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000427:0
454,153 shares0Common stock, par value $0.001SEC:0001415889-25-000400:0
49,383 shares0common stock, par value $0.001SEC:0001415889-25-000426:0
763,359 shares@ US$1.8420.5% of flowCommon stock, par value $0.001SEC:0001415889-24-023957:0
Canonical exit: 22 Dec 2024 (T+90)
5,000 shares@ US$7.48350.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079855:0
Canonical exit: 9 Oct 2024 (T+90)
5,000 shares@ US$7.39420.6% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079100:0
Canonical exit: 7 Oct 2024 (T+90)
25 of 80 declarations
关于 Fortress Biotech, Inc.
Fortress Biotech, Inc. 是一家专注于开发创新疾病治疗方法的公司。该公司主要在医疗保健和制药领域运营，并在纳斯达克上市。